METTL14 and nonpapillary renal cell carcinoma: Hopefully, the METTL14/ITGB4 axis has great potential to serve as a diagnostic or therapeutic target for ccRCC in the future, while its impacts on other signaling pathways and other cancerous behaviors are worthy to further explore.